Response of hormone refractory prostate cancer to lycopene.
Matlaga
B R
BR
Department of Urology and Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Hall
M C
MC
Stindt
D
D
Torti
F M
FM
D000230:Adenocarcinoma / Q000188:drug therapy*; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D002338:Carotenoids / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use; D000077276:Lycopene; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D016588:Anticarcinogenic Agents; D002338:Carotenoids; D016729:Leuprolide; D000077276:Lycopene